Post-Exposure Prophylaxis: Timing and Effectiveness

Medication consultation

Hello doctor, I had unprotected intercourse with a sex worker and took post-exposure prophylaxis approximately 70 hours later, consisting of Cabotegravir and Tenofovir.
I took two Cabotegravir tablets and one Tenofovir tablet daily.
I took the first Cabotegravir tablet within 72 hours, but the first Tenofovir tablet was taken after 72 hours.
Will this still be effective? Will it have any impact?

K, 20~29 year old female. Ask Date: 2017/06/16

Dr. Hong Yuanbin reply Internal Medicine

Hello, any prophylactic medication will have a certain degree of preventive effect; however, a slight delay may slightly reduce its effectiveness.
Nonetheless, no preventive measure is 100% effective.
Regular follow-up is still recommended to confirm whether an infection has occurred.
Thank you for your question.

Reply Date: 2017/06/16

More Info

Post-Exposure Prophylaxis (PEP) is a critical intervention for individuals who may have been exposed to HIV, particularly through unprotected sexual intercourse. The effectiveness of PEP is highly dependent on the timing of administration, as well as the specific medications used.

In your case, you mentioned that you took the first dose of Cabotegravir (卡貝滋) within 72 hours after potential exposure, which is within the recommended window for PEP. Cabotegravir is an antiretroviral medication that is effective in preventing HIV infection when taken as directed. The key point is that PEP should ideally be started as soon as possible after potential exposure, and it is most effective when initiated within 72 hours.

However, you also noted that you took the first dose of Tenofovir/Emtricitabine (希寧) after the 72-hour window. This raises some concerns regarding the overall effectiveness of the PEP regimen. While Cabotegravir can still provide some level of protection if taken within the appropriate timeframe, the delayed initiation of Tenofovir/Emtricitabine may reduce the overall efficacy of the PEP treatment.
The general recommendation for PEP is to take a combination of antiretroviral medications for 28 days, and it is crucial to adhere to the prescribed regimen without delays. Missing doses or taking them outside the recommended time frame can compromise the effectiveness of the treatment.
In terms of the specific question about whether the delayed administration of Tenofovir/Emtricitabine will affect the efficacy of the PEP regimen, it is important to understand that while Cabotegravir may still offer some protection, the overall effectiveness of the PEP may be diminished due to the late initiation of the second medication.
It is also essential to follow up with a healthcare provider for further evaluation and possibly additional testing. They may recommend regular follow-up HIV testing after completing the PEP regimen to ensure that no infection has occurred.
In summary, while you have taken the first dose of Cabotegravir within the recommended time frame, the delayed initiation of Tenofovir/Emtricitabine may impact the overall effectiveness of your PEP regimen. It is crucial to adhere to the prescribed treatment and consult with a healthcare provider for further guidance and monitoring. Additionally, consider discussing other preventive measures, such as regular testing and the use of condoms, to reduce the risk of HIV transmission in the future.

Similar Q&A

Understanding Post-Exposure Prophylaxis (PEP) Testing and Symptoms

Hello Dr. Liao, I engaged in sexual activities on March 17, which included approximately 30 seconds of unprotected oral sex and about 1 to 3 minutes of protected vaginal intercourse. There were around 10 thrusts, but the condom was not fitted properly. When I withdrew, only the t...

Dr. Liao Zhongxin reply Internal Medicine
Dear readers: Regarding the topic of body temperature fluctuations and sweating after fever, here is the response: A: 1. If prophylactic treatment (PEP) was initiated within 66 hours and completed a 4-week course on April 16, you should be able to feel reassured. 2. Since the w...

Understanding HIV Transmission Risks After PEP: Key Insights

I started post-exposure prophylaxis (PEP) with Biktarvy 38 hours after high-risk exposure to HIV. However, 44 hours after the exposure, which is 6 hours after starting the medication, I engaged in unprotected sexual intercourse with my ex-girlfriend. My initial intention was to a...

Dr. Cai Zhuorong reply Urology
The situation you described does have a low chance of transmission. However, there are no specific reports in the medical literature providing clear data, as such experiments cannot be conducted. It is advisable to maintain safe sexual practices and to have your girlfriend underg...

Understanding Post-Exposure Prophylaxis: Your Questions Answered

Hello Doctor, I apologize for bothering you during your busy schedule. In early October, I had unprotected oral sex and protected vaginal intercourse. The next day, I underwent nPEP treatment. After 6 weeks and 3 months, both tests were negative. The doctor at Asia University Hos...

Dr. Hong Yuanbin reply Internal Medicine
Hello, based on your description, the likelihood of contracting HIV is indeed very low. If there are no related symptoms or concerns about repeated exposure, it may not be necessary to follow up for six months. Thank you for your question.

Post-Exposure Prophylaxis: Symptoms and Concerns After Risky Encounter

Hello Doctor, I engaged in high-risk sexual behavior with a sex worker on August 31st at noon. That evening at 7 PM, I immediately registered at the infectious disease department, and at 8 PM, I started taking PEP (post-exposure prophylaxis) with Tenofovir. However, since last we...

Dr. Hong Yuanbin reply Internal Medicine
Hello, 1. Your symptoms are more indicative of an allergic reaction or eczema, and it may not necessarily be a treatment failure. Whether you are HIV positive can only be determined through testing. 2. The incidence of HIV infection after prophylactic treatment failure is very...